Removing the primary tumour in metastatic breast cancer

被引：4
作者：
Cameron, David [1 ]
机构：
[1] Univ Edinburgh, Western Gen Hosp, Canc Res Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 13期
关键词：
OPEN-LABEL; TRASTUZUMAB; PERTUZUMAB; PHASE-2; GROWTH; TRIAL;
D O I：
10.1016/S1470-2045(15)00221-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1284 / 1285
页数：3
相关论文
共 50 条
  • [21] Breast surgery for metastatic breast cancer
    Tosello, Giuliano
    Torloni, Maria Regina
    Mota, Bruna S.
    Neeman, Teresa
    Riera, Rachel
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (03):
  • [22] Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
    Van Raemdonck, Elisa
    Floris, G.
    Berteloot, P.
    Laenen, A.
    Vergote, I.
    Wildiers, H.
    Punie, K.
    Neven, P.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 183 - 194
  • [23] Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?
    Dempsey, Naomi
    Sandoval, Ana
    Mahtani, Reshma
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (09) : 1120 - 1137
  • [24] Updated Austrian treatment algorithm in HER2+metastatic breast cancer
    Bartsch, Rupert
    Gampenrieder, Simon Peter
    Rinnerthaler, Gabriel
    Petru, Edgar
    Egle, Daniel
    Petzer, Andreas
    Balic, Marija
    Pluschnig, Ursula
    Sliwa, Thamer
    Singer, Christian
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (1-2) : 63 - 72
  • [25] Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review
    Lebert, Julie
    Lilly, Evan J.
    [J]. CURRENT ONCOLOGY, 2022, 29 (04) : 2539 - 2549
  • [26] Whether to determine HER2 status for breast cancer in the primary tumour or in the metastasis
    Santiago, M. P.
    Vazquez-Boquete, A.
    Fernandez, B.
    Masa, C.
    Antunez, J. R.
    Fraga, M.
    Forteza, J.
    Garcia-Caballero, T.
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2009, 24 (06) : 675 - 682
  • [27] Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case series
    Bergin, Alice R. T.
    Luen, Stephen J.
    Savas, Peter
    Boolell, Vishal
    Cho, Doah
    Lynch, Jodi
    Nott, Louise
    Stuart-Harris, Robin
    Teo, Lee Na
    Yap, Saw Yee
    Loi, Sherene
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (06) : 377 - 382
  • [28] Treatment of Metastatic Breast Cancer
    Gradishar, William J.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (5.5): : 759 - 761
  • [29] Trastuzumab in metastatic breast cancer
    Tomao, F.
    Miele, E.
    Spinelli, G. P.
    Russillo, M.
    La Ferla, G.
    Tomao, S.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (03) : 247 - 249
  • [30] Lapatinib in metastatic breast cancer
    Frenel, J-S
    Bourbouloux, E.
    Berton-Rigaud, D.
    Sadot-Lebouvier, S.
    Zanetti, A.
    Campone, M.
    [J]. WOMENS HEALTH, 2009, 5 (06) : 603 - 612
12345